LONDON – AstraZeneca PLC said Tuesday that a European patent has been revoked covering the use of its Symbicort medicine as a treatment for a condition commonly known as "smoker’s cough." AstraZeneca ...

The dosage for Symbicort may vary based on age and diagnosis, but it’s typically two inhalations twice daily. For children ages 6 to 11, the maximum strength is 80/4.5 mcg. For ages 12 and older, a ...

This could increase to 38% by 2008, with sales of over $1.2 billion, with the benefit of the new labeling, it added. AstraZeneca originally filed for approval of this so-called SMART (Symbicort ...

Symbicort, which is used to treat chronic obstructive pulmonary disease and asthma, can cause side effects. Mild side effects include nasal congestion and headaches. Serious side effects include ...